Titan Biotech Ltd

₹ 324 3.09%

27 Oct 9:58 a.m.

About

Incorporated in 1992, Titan Biotech
Ltd manufacturer and exporter of
the Biological products^[1]

Key Points

Business Overview ^[1]
The company is a leading manufacturer and exporter of biological products and premium-quality raw material ingredients for the pharmaceutical, nutraceutical, cosmeceutical, food & beverage, biotechnology, fermentation, veterinary, animal nutrition, agriculture, and microbiology industries

Website BSE

Market Cap ₹ 1,673 Cr.
Current Price ₹ 324
High / Low ₹ 445 / 137
Stock P/E 54.4
Book Value ₹ 33.1
Dividend Yield 0.12 %
ROCE 24.1 %
ROE 17.4 %
Face Value ₹ 2.00

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Company is expected to give good quarter

Cons

Stock is trading at 9.49 times its book value
The company has delivered a poor sales growth of 11.0% over past five years.
Dividend payout has been low at 7.85% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE Commodities

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	34.75	43.43	45.98	39.92	43.11	39.89	38.28	35.17	46.50	54.35	56.51	48.83	59.17
	26.86	34.71	35.38	32.85	34.86	32.13	33.43	30.60	37.76	45.02	45.68	39.12	46.68
Operating Profit	7.89	8.72	10.60	7.07	8.25	7.76	4.85	4.57	8.74	9.33	10.83	9.71	12.49
OPM %	22.71%	20.08%	23.05%	17.71%	19.14%	19.45%	12.67%	12.99%	18.80%	17.17%	19.16%	19.89%	21.11%
	0.28	0.55	0.44	0.48	0.62	0.32	1.59	1.38	0.72	1.32	1.26	2.11	1.81
Interest	0.29	0.28	0.26	0.34	0.31	0.27	0.15	0.08	0.20	0.22	0.26	0.24	0.20
Depreciation	0.80	0.86	0.83	0.84	1.05	1.10	1.18	0.84	1.15	1.21	1.27	1.30	1.37
Profit before tax	7.08	8.13	9.95	6.37	7.51	6.71	5.11	5.03	8.11	9.22	10.56	10.28	12.73
Tax %	23.73%	25.71%	25.63%	24.02%	24.23%	25.48%	25.64%	25.25%	24.04%	25.60%	25.57%	36.19%	25.77%
	5.41	6.03	7.38	4.84	5.70	5.00	3.80	3.77	6.16	6.86	7.87	6.56	9.46
EPS in Rs	1.05	1.17	1.43	0.94	1.11	0.97	0.74	0.73	1.20	1.33	1.53	1.27	1.83
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	40	46	52	56	58	69	122	124	144	164	156	206	219
	36	42	47	49	51	59	81	92	114	130	131	168	176
Operating Profit	4	4	6	7	8	11	42	31	30	34	25	39	42
OPM %	10%	9%	10%	12%	13%	16%	34%	25%	21%	21%	16%	19%	19%
	0	0	0	0	1	1	0	1	2	2	4	5	6
Interest	1	1	1	2	2	2	1	1	1	1	1	1	1
Depreciation	1	1	1	1	2	2	2	2	3	3	4	5	5
Profit before tax	2	3	3	4	4	8	39	29	28	32	24	38	43
Tax %	33%	33%	33%	36%	29%	25%	26%	25%	25%	25%	25%	28%
	2	2	2	2	3	6	29	22	21	24	18	27	31
EPS in Rs	0.34	0.35	0.48	0.49	0.60	1.20	5.59	4.21	4.08	4.59	3.55	5.32	5.96
Dividend Payout %	36%	34%	25%	24%	0%	13%	4%	6%	7%	7%	9%	8%

Compounded Sales Growth
10 Years:	16%
5 Years:	11%
3 Years:	13%
TTM:	37%

Compounded Profit Growth
10 Years:	32%
5 Years:	-1%
3 Years:	9%
TTM:	64%

Stock Price CAGR
10 Years:	45%
5 Years:	46%
3 Years:	76%
1 Year:	72%

Return on Equity
10 Years:	21%
5 Years:	19%
3 Years:	17%
Last Year:	17%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	8	8	8	8	8	8	8	8	8	8	8	8
Reserves	13	14	15	17	23	30	58	78	98	120	137	163
	8	11	22	25	22	18	10	9	9	8	3	6
	5	6	5	5	6	10	10	13	16	15	19	27
Total Liabilities	34	39	50	55	60	65	86	108	131	152	166	203
	11	10	11	11	26	25	27	35	36	52	57	62
CWIP	1	5	9	13	0	0	0	4	13	3	2	2
Investments	0	1	1	1	1	1	1	4	12	23	24	50
	21	23	29	29	33	39	58	65	70	74	83	90
Total Assets	34	39	50	55	60	65	86	108	131	152	166	203

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-2	5	-0	2	6	7	18	22	21	21	20	30
	-3	-5	-7	-5	-4	-1	-4	-16	-21	-20	-10	-33
	3	2	8	0	-2	-6	-10	-4	-2	-3	-8	-2
Net Cash Flow	-2	2	2	-3	1	0	4	2	-2	-2	2	-4
Free Cash Flow	-3	1	-6	-3	2	6	13	8	8	12	12	23
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	-28%	143%	18%	39%	95%	78%	66%	93%	97%	85%	103%	101%

Ratios

Standalone / View Consolidated

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	58	46	44	53	49	55	48	48	53	42	44	40
Inventory Days	134	118	155	202	238	244	177	206	179	208	243	202
Days Payable	17	18	13	12	25	36	18	25	27	15	36	31
Cash Conversion Cycle	175	145	186	243	262	263	207	230	205	234	250	211
Working Capital Days	94	58	86	111	101	105	89	118	109	112	131	102
ROCE %	14%	12%	13%	13%	13%	18%	61%	35%	28%	26%	18%	24%

Insights

In beta

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Coal Consumption
Tonnes

xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	x,xxx.xx	xxx.xx	x.xx	x.xx	x.xx
x.xx	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx
xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx
xxx	xxx	xxx	xxx	xxx	xxx	xxx	xxx	xxx	xxx	xxx
x,xxx,xxx.xx	x,xxx,xxx.xx	x,xxx,xxx.xx	x,xxx,xxx.xx	x,xxx,xxx.xx	x,xxx,xxx.xx	x,xxx,xxx.xx	x,xxx,xxx.xx	x,xxx,xxx.xx	x,xxx,xxx.xx	x,xxx,xxx.xx
						x.xx	xxx,xxx.xx	xxx,xxx.xx	xxx,xxx.xx	x,xxx,xxx.xx
xxx,xxx.xx	xxx,xxx.xx	x,xxx,xxx.xx
x,xxx,xxx.xx	x,xxx,xxx.xx	x,xxx,xxx.xx

Please log in to see hidden values.

Electricity Consumption per Unit of Production
Units/kg

Export Revenue Share
%

Permanent Employees
count

Total Electricity Consumption
Units

PNG Gas Consumption
Units

Peptone Production Volume
Kgs

Total Production Volume (All Products)
Kgs

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	55.87%	55.87%	55.87%	55.87%	55.87%	55.87%	55.87%	55.78%	55.78%	55.78%	55.78%	55.78%
	0.00%	0.23%	0.00%	0.00%	0.00%	0.01%	0.03%	0.03%	0.03%	0.03%	0.01%	0.01%
	44.12%	43.90%	44.12%	44.13%	44.12%	44.11%	44.10%	44.19%	44.19%	44.19%	44.21%	44.21%
No. of Shareholders	15,756	15,876	15,850	15,700	16,038	16,370	16,328	16,040	16,367	17,457	18,671	19,049

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Sep 2026
	48.00%	48.00%	49.49%	54.35%	55.88%	55.88%	55.87%	55.87%	55.87%	55.78%	55.78%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.23%	0.01%	0.03%	0.01%
	52.00%	52.00%	50.51%	45.65%	44.12%	44.12%	44.12%	43.90%	44.11%	44.19%	44.21%
No. of Shareholders	8,698	8,680	8,226	8,498	13,086	20,097	18,752	15,876	16,370	17,457	19,049

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Titan Biotech Ltd

Titan Biotech Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports